Salific Pharmaceuticals Private Limited

Founded in 2018 and headquartered in Uttar Pradesh, India.

2018 | Shrawasti, Uttar Pradesh (India) | Active
Last Updated:

Salific Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 18 Days
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth 35.73%
  • Profit Growth 35.36%
  • Ebitda -21.06%
  • Net Worth -170.09%
  • Total Assets 88.54%

About Salific Pharmaceuticals

Salific Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 February 2018 (Seven years 18 days old ). Its registered office is in Shrawasti, Uttar Pradesh, India.

The Company is engaged in the Business Services Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Sujeet Saini and Hari Saini serve as directors at the Company.

Company Details

  • Location

    Shrawasti, Uttar Pradesh, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U74999UP2018PTC101389

  • Company No.

    101389

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    26 Feb 2018

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Kanpur

Industry

Business Services
Company report

Salific Pharmaceuticals Private Limited

Explore comprehensive data for Salific Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Salific Pharmaceuticals?

Board Members (2)

NameDesignationAppointment DateStatus
Sujeet Saini Country flag representing In Director 26-Feb-2018Current
Hari Saini Country flag representing In Director 26-Feb-2018Current

Financial Performance of Salific Pharmaceuticals.

Salific Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 35.73% increase. The company also saw a substantial improvement in profitability, with a 35.36% increase in profit. The company's net worth observed a substantial decline by a decrease of 170.09%.

Salific Pharmaceuticals revenue growth over time
Salific Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
35.73%
Revenue from Operations
35.73%
Total Assets
88.54%
Profit or Loss
35.36%
Net Worth
-170.09%
EBITDA
-21.06%

What is the Ownership and Shareholding Structure of Salific Pharmaceuticals?

Unlock access to Salific Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Salific Pharmaceuticals?

Unlock and access historical data on people associated with Salific Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Salific Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Salific Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Salific Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Salific Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Salific Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Salific Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur.

  • Director Appointment

    Sujeet Kumar Saini was appointed as a Director was appointed as a Director on 26 Feb 2018 & has been associated with this company since 7 years 18 days .

  • Director Appointment

    Hari Kumar Saini was appointed as a Director was appointed as a Director on 26 Feb 2018 & has been associated with this company since 7 years 18 days .

  • Company Incorporation

    Salific Pharmaceuticals Private Limited was registered on 26 Feb 2018 with Roc Kanpur & aged 7 years 18 days as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Salific Pharmaceuticals Private Limited?

    Salific Pharmaceuticals Private Limited was incorporated on 26 Feb 2018.

  • What is authorized share capital and paid-up capital of Salific Pharmaceuticals Private Limited?

    The authorized share capital of Salific Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Who are the current board members & directors of Salific Pharmaceuticals Private Limited?

    Currently 2 directors are associated with Salific Pharmaceuticals Private Limited.

    • Sujeet Kumar Saini
    • Hari Kumar Saini
  • What is the registered address of Salific Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Salific Pharmaceuticals Private Limited is S/O Late Sri Kamta Prasad H No. 354 Nahar Balaganj, India, Balrampur, Uttar Pradesh, 271201.

  • What is the corporate identification number (CIN) and company number of Salific Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Salific Pharmaceuticals Private Limited is U74999UP2018PTC101389 and the company number is 101389 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Salific Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2022, the revenue trend for Salific Pharmaceuticals Private Limited has risen by 35.73%.

  • What change has been observed in the net worth of Salific Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2022 indicates that The net worth of Salific Pharmaceuticals Private Limited has experienced an downturn of -170.09%.

  • When was the last Balance Sheet of Salific Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Salific Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial